iShares 1 3 Year Treasury Bond ETF vs Teladoc Health Inc — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 26.4× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 1 3 Year Treasury Bond ETF for 63 Days and Teladoc Health Inc for 39 Days on average.
| SHY | TDOC | |
|---|---|---|
Market Cap | $26.68B | $1.01B |
Volume | 4,077,691 | 4,668,477 |
Sector | Fixed Income | Health |
52-Week High | $83.18 | $9.72 |
52-Week Low | $81.05 | $4.47 |
Typical Hold Time | 63 Days | 39 Days |
Enterprise Value | — | $1.27B |
Signals from Pluang's Aura AI — not financial advice
SHY trades at $81.20 with minimal daily movement (+0.05%), reflecting stability amid broader bond market volatility. Technical indicators show a bearish trend with moving averages signaling caution, while oscillators remain neutral. Recent dividend payments of $0.24-$0.25 per share provide income stability, though key financial ratios are unavailable for fundamental assessment. The bond ETF faces headwinds from rising Treasury yields and inflation concerns.
Outlook remains cautious as rising interest rates pressure bond ETFs, though SHY's short-term focus may offer relative safety. Key risks include prolonged high yields and economic uncertainty. Investment appeal hinges on income generation in a volatile rate environment, with technical weakness suggesting limited near-term upside.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →